Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-23-016027
Filing Date
2023-05-30
Accepted
2023-05-30 07:48:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A mbrx20230529_defa14a.htm DEFA14A 27127
  Complete submission text file 0001437749-23-016027.txt   28112
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37758 | Film No.: 23971410
SIC: 2834 Pharmaceutical Preparations